$LLY · Eli Lilly and Company

Eli Lilly and Company filed a Form 3 with the Securities and Exchange Commission on October 8, 2026, reporting an initial beneficial ownership position in TRex Bio, Inc., which trades under the symbol TRXB. A Form 3 is a required disclosure when a reporting person first becomes subject to Section 16 ownership reporting requirements.

In the filing, Eli Lilly reported direct ownership of 5,480,872 shares of TRex Bio common stock. According to the filing, that total consists of 4,605,872 shares issuable upon mandatory conversion of convertible preferred stock, plus 875,000 shares being purchased by Eli Lilly in TRex Bio's initial public offering.

The filing does not report a sale or a change in an existing position; it establishes the company's initial reported holdings in TRex Bio.